Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000001734
JPRN-UMIN000001734
Completed
未知

The study of gene polymorphisms and urinary prostaglandins in relation to the development of the overactive bladder - The study of gene polymorphisms and urinary prostaglandins in relation to the development of the overactive bladder

Department of Urology, Faculty of Medical Science, University of Fukui0 sites180 target enrollmentStarted: February 25, 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOveractive bladder

Overview

Phase
未知
Status
Completed
Sponsor
Department of Urology, Faculty of Medical Science, University of Fukui
Enrollment
180
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\) Patients with urinary tract infection 2\) Patients who are treated with non\-steroid\-anti\-inflammatory\-drugs, antimuscarinics and alfa\-1\-blockers

Investigators

Sponsor
Department of Urology, Faculty of Medical Science, University of Fukui

Similar Trials

Completed
Not Applicable
Prostagen Study - Investigation of polymorphisms in genes of the fatty acid metabolism in relation to the evolvement and further development of prostate cancerC61Malignant neoplasm of prostate
DRKS00000319Klinik für Tumorbiologie158
Completed
Not Applicable
An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian MalesProstate Cancer
NCT00342771National Cancer Institute (NCI)2,033
Recruiting
Phase 1
Molecular epidemiological analysis of prostate cancer in Hunan populatioprostate cancer
ITMCTR2200005999the First Affiliated Hospital of Hunan University of Chinese Medicine
Recruiting
Not Applicable
Investigation of influence of genetic polymorphisms of drug metabolizing enzymes and transporters, including SLCO1B3 and ABCC2, on Docetaxel Pharmacokinetics in advanced Non Small Cell Lung Cancer Patientson-Small Cell Lung Cancer
JPRN-UMIN000003723Research institute for diseases of the chest, Kyushu University50
Active, not recruiting
Phase 2
Assessing the use of tailored treatments based on combinations of genes that are active in a tumour, and the impact on outcomes for bladder cancer.
ISRCTN17378733Sheffield Teaching Hospitals NHS Foundation Trust320